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ABSTRACT
Objective: The study was carried out to investigate the antidiarrheal activity of ethanolic leaf extract of Eriobotrya japonica (EEJ) using various 
models of experimental diarrhea.
Methods: Antidiarrheal property of EEJ at 100, 200, and 400 mg/kg/bwt was evaluated using castor oil-induced diarrhea, castor oil-induced 
enteropooling, and gastrointestinal propulsive models of experimental diarrhea in Sprague Dawley rats of both sexes, weighing 200–250 g. Cytotoxicity 
test of EEJ was performed using brine shrimp bioassay.
Results: Toxicity assay of EEJ showed a lethal concentration value of 1225 µg/ml suggesting non-toxicity. EEJ significantly (p<0.05) and 
dose-dependently (100, 200 and 400 mg/kg/bwt) inhibited castor oil-induced diarrhea by 38.1%, 76.19%, and 100%, respectively, and enteropooling 
by 28%, 56%, and 88%, respectively, compared with control. Pre-treatment with yohimbine, α2-adrenoceptor blocker significantly reversed the 
protective effect of EEJ (400 mg/kg) against castor oil-induced diarrhea and against castor oil-induced enteropooling, suggesting the involvement of 
α2-adrenoceptors in antidiarrheal property of EEJ. Furthermore, EEJ significantly (p<0.05) and dosedependently (100, 200, and 400 mg/Kg/bwt) 
inhibited gastrointestinal motility by 28%, 62%, and 83.92%, respectively.
Conclusion: The study has demonstrated the antidiarrheal potential of ethanolic leaf extract of EEJ, which may be attributable to its dual antisecretory 
and antimotility activities probably through activation of the sympathetic α2-adrenergic pathway.
Keywords: Eriobotrya japonica, Enteropooling, α2-adrenoceptors, Cytotoxicity, Anti-secretory.
INTRODUCTION
Diarrhea is a common gastrointestinal disorder affecting people of all 
ages worldwide. Diarrhea is usually characterized by the passage of a 
large volume of loose or watery stool at an increased frequency usually 
3–4 times a day or stool volume >200 ml/day irrespective of the cause, 
be it infectious or not [1-3]. Diarrhea results from an imbalance between 
absorption and secretory processes that occur in the intestinal mucosa, 
and it is associated with excessive loss of essential electrolytes such as 
sodium ions, potassium ions, and chloride ions leading to dehydration 
and electrolyte imbalances [4,5]. Diarrheal diseases are usually 
associated with low living standards, poor sanitation infrastructure 
and poor access to portable, and safe-treated water sources [6,7]. Many 
rural dwellers depend mostly on the pond and river waters, whereby 
the community members share with household animals [8,9]. Reports 
suggest that about 2.4 billion people do not have basic sanitation 
with 1.1 billion people lacking access to improved and treated water 
supply worldwide [10]. South Africa is commended for achieving the 
water and sanitation targets for the millennium development goal 
with over 90% of South Africans having access to clean public water. 
However, estimates indicate that there are 6 million households and 1.4 
million households which still lack access to clean water and sanitation 
services, respectively [11], putting this group of people at risk of getting 
diarrheal diseases.
Diarrhea leads to death if dehydration and electrolyte loss persist 
and become too severe without rehydration or treatment [12,13]. 
Worldwide, diarrhea claims several million lives annually and is 
reportedly to be the second leading cause of deaths mostly those of 
infants [14]. For instance, global mortality estimate from diarrhea is 
reported to be over 1.5 million deaths of children under the age of five 
annually [15]. In 1998, a estimated number of people killed by diarrhea 
worldwide were 7.1 [16]. The prevalence and incidences of diarrhea 
are on the rise especially in developing nations including South Africa. 
For instance, every year, South Africa reports about 3 million incidents 
of diarrheal cases requiring treatment. Furthermore, in South Africa 
alone, every year, and diarrheal diseases are claimed to be responsible 
for about 43000 deaths, with under five deaths accounting for 20% [17].
Diarrhea is treated with a number of available conventional drugs 
the most efficacious of which is loperamide, which acts both as 
antisecretory and antimotility drug in the intestines [18]. However, 
use of these conventional drugs has some limitations as some 
present with undesirable effects such as vomiting, fever, constipation, 
bronchospasms, dry mouth, and abdominal pains among others [19] 
and in addition, most infectious diarrhea are treated with a course 
of antibiotics, which currently is faced with massive drug-resistant 
challenges [20,21]. Furthermore, they are expensive and not easily 
accessible to ordinary poor rural communities. In most cases, they are 
not even available due to lack of adequate health facilities such as clinics 
and hospitals that are located at a very far distance from the community 
members [22]. It is because of these limitations that people resort to 
use of herbal remedies and other alternative treatments which have 
been perceived to be effective, affordable, and accessible and indeed 
with fewer or no side effects.
Worldwide, about 80% of communities rely on herbal remedies to treat 
various human ailments including diarrhea and other gastrointestinal 
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disorders [23]. Moreover, the WHO has encouraged the use of traditional 
medicinal plants for the treatment and prevention of diarrhea 
worldwide [24,25]. A number of medicinal plants have been evaluated 
for their antidiarrheal properties, and reports indicate that they 
possess antispasmodic activities, delay gastrointestinal transit, inhibit 
motility of the gut, and reduce the intraluminal fluid accumulation 
with a concomitant enhancement of water and ion absorption [26,27]. 
Eriobotrya japonica (EEJ) Lindl. commonly known as loquat tree is one 
of such plants which is popularly and commonly used in the traditional 
medicine practice by several communities in treating various human 
diseases including diarrhea and other gastrointestinal-associated 
disorders by many rural communities of South Africa, especially in 
the Eastern Cape Province. Several biological activities of this plant 
have been reported. For instance, extracts obtained from this plant 
are reported to possess anti-inflammatory, antidiabetic, antioxidant, 
antiallergy, hyperleptinemia, hyperinsulinemia, and several other 
disorders [28-32]. Despite its long traditional use in the treatment of 
diarrhea, there is little documented scientific information regarding its 
antidiarrheal properties. The present study, was, therefore, conducted 
to scientifically evaluate the antidiarrheal effect of ethanolic leaf extract 
of EEJ using various models of diarrhea in an attempt to establish its 
efficacy and possible mechanism(s) of actions.
METHODS
Plant material
Leafy parts of EEJ were collected from areas surrounding Walter Sisulu 
University, Mthatha Campus. Identification and authentication of the 
plant were done by a senior taxonomist of the herbarium section, 
Department of Biological Sciences Walter Sisulu University, Mthatha 
Campus. A herbarium specimen was prepared and deposited with a 
voucher number: Nomathithi 1 (KEI).
Preparation of ethanolic leaf extract of EEJ
The leaves were shredded and allowed to air-dry under shade at room 
temperature for 3 w. The dried leaves were then milled into powder 
using a commercial blender. The powdered material was soaked in 
70% ethanol and allowed to stay for 2 d with continuous shaking using 
(Labcon) platform shaker machine at room temperature. The resultant 
mixture was filtered using Whatman No. 1 filter paper in Buchner 
funnel. The filtrate was concentrated using the rotary evaporator under 
reduced pressure at 55°C. The semi-solid concentrated extract was 
finally dried in an oven at 40°C to obtain a crude extract which was 
designated EEJ and was kept in a bio-freezer at −75°Cuntil the day of 
experiments.
Animals
Sprague Dawley rats of both sexes, weighing 200–250 g were used 
for the study. Rats were supplied by Shalom Laboratories and housed 
in the storage facility in the Department of Physiology, Walter Sisulu 
University. The animals were kept in polypropylene open top cages (four 
in each cage) and were maintained at an ambient temperature of 25 ± 
2°C and 12 h light/12 h dark regime. The animals were acclimatized 
to the animal housing storage unit and laboratory conditions for 2 w 
before the commencement of the experiment and during this period 
animals were fed with standard rat pellet chow (Epol SA) and water ad 
libitum. The experimental protocol and all procedures were approved 
by the Faculty of Health Sciences Research Ethics Committee, Walter 
Sisulu University. Animals were handled in compliance with the Guide 
for care and use of Laboratory Animals (NIP Publication No. 85 (23), 
revised in 1996).
Experimental design
The cytotoxicity test of the extract was performed using Brine Shrimp 
lethality bioassay. To establish the antidiarrheal activity of EEJ, the 
extract was screened against various models of diarrhea, namely castor 
oil-induced diarrhea, castor oil-induced enteropooling, and castor oil-
induced gastrointestinal propulsion in rats. Before commencement of 
the experiments, the rats were fasted either for 18 or 24 h depending 
on the experimental procedure. Administration of the extract and 
loperamide was performed by intragastric gavage using straight 
feeding needles suitable for the animal depending on its size, whereas 
yohimbine and atropine were administered intraperitoneally (i.p) in 
live animals.
Determination of cytotoxicity of EEJ
The cytotoxic effect of EEJ was carried out using Brine shrimp lethality 
bioassay according to the model described by Nguta et al. [33], with 
slight modification. Brine shrimps (Artemia salina) were hatched 
using brine shrimp eggs in a rectangular vessel, containing 2L of 
sterile artificial seawater (prepared using NaCl 38 g/L) under constant 
aeration for 48 h, with artificial light shone on the opposite side of 
the rectangular hatchery. After hatching was achieved, active nauplii 
were collected from the brighter side of the hatchery and used for 
the assay. 10 nauplii were drawn through a glass capillary and placed 
into vials containing 4 ml of brine solution for the control, and for the 
experimental groups, 10 nauplii were placed in 4 ml of brine solution. 
The vial for the control group contained brine solution only, whereas 
the vials for experimental groups contained brine solution and EEJ of 
various concentrations (1000 µg/ml, 500 µg/ml, 250 µg/ml, 125 µg/ml, 
62.5 µg/ml, and 31.25 µg/ml) with 3 duplicates per concentration. The 
mixtures were maintained at room temperature under constant light, 
and a 24 h survival larvae count was recorded. The mortality rate was 
determined as follows:
% deaths=[(Total nauplii-Alive nauplii)/Total nauplii]×100%
Lethal concentration (LC50) determination
The median LC50 in µg/ml, 95% confidence interval and slope was 
determined after the 24 h count using the probit statistical analysis 
method [34]. LC50 value of >1000 µg/ml is considered non-toxic, LC50 
value ≥500 µg/ml and ≤1000 µg/ml is considered weak toxic, and LC50 
value <500 µg/ml is considered toxic [35].
Effect of EEJ on castor oil-induced diarrhea in rats
The antidiarrheal property of EEJ against castor oil-induced diarrhea 
was performed using a method described by Zavala-Mendoza et al. [36] 
with slight modifications. In brief, the rats were fasted for 18 hours 
before the commencement of the experiment with free access to water. 
A total number of 42 rats were randomly allocated into 7 groups with 6 
rats per group as follows:
Group I was administered with normal saline (2 ml/Kg/bwt) 
and acted as a negative control group. Groups II, III, and IV were 
administered 100, 200, and 400 mg/kg/bwt of EEJ, respectively. 
Group V was administered loperamide, a standard antidiarrheal 
drug at a dose of 5 mg/kg/bwt and acted as a positive control. In a 
separate experiment, rats in Groups VI and VII were pre-treated with 
yohimbine (1 mg/kg/bwt) a selective α2 adrenergic receptor blocker 
and prazosin (1mg/kg/bwt.), a selective α1 adrenergic receptor 
blocker respectively, 30 min before the dose of 400 mg/kg of EEJ 
was administered. After 1 h of various doses of EEJ and loperamide 
administration, 2 ml/kg/bwt of castor oil was administered orally to 
each rat to induce diarrhea. The animals were placed in individual 
cages lined with adsorbent papers. The cages were then observed 
for 4 h for the presence of characteristic diarrheal droppings. Time 
for the onset of diarrhea, total number of wet droppings and semi-
solid droppings was recorded for each cage during the 4 h period of 
observation. The time for onset was measured as the time interval 
between the administration of castor oil and the first appearance 
of wet droppings in minutes. The absence of wet droppings was 
considered as protection from diarrhea, and the percentage 
protection was calculated according to the formula described by 
Umukoro and Ashorobi [37] as follows:
[(NWDC-NWDT)/NWDC]×100.
Where NWDC=Number of wet droppings in control group and 
NWDT=Number of wet droppings in treatment groups.
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Effect of EEJ on gastrointestinal propulsion in rats
The effect of EEJ on gastrointestinal transit (motility) was investigated 
in rats using a method described by Marona and Lucchesi [38] with a 
slight modification. In brief, the rats were fasted for 24 h before the 
commencement of the experiment with free access to water. 36 rats 
were randomly allocated into 6 groups with 6 rats per group as follows:
Group I was given 2 ml/kg/bwt of normal saline and acted as a negative 
control group. Groups II, III, and IV were administered 100, 200, and 
400 mg/kg/bwt of EEJ, respectively. To check whether EEJ has antimotility 
activity comparable to drugs with known antigastrointestinal motility, rats 
in Group V were given atropine sulfate (0.3 mg/kg/bwt i.p) muscarinic 
receptor antagonist. In a separate experiment, rats in Group VI were 
pre-treated with yohimbine (1 mg/kg/bwt i.p) a selective α2 adrenergic 
receptor blocker, 30 min before the dose of 400 mg/kg of EEJ was 
administered. After 1 h of administration of the normal saline, different 
doses of EEJ and atropine sulfate, each animal was given 2 ml of the 
standard charcoal meal (10% activated charcoal suspension in 2% tween 
80) and 1 ml of castor oil. After 1 hour of charcoal meal administration, 
each rat was sacrificed by cervical dislocation, and its abdomen was 
opened by midline incision. The small intestine was immediately isolated. 
The total length of the intestine from pylorus to caecum (total length of 
small intestine) and the distance traveled by the charcoal (length traveled 
by charcoal meal) were measured using a ruler in centimeters (cm). 
The peristaltic index (PI) for each rat was calculated and expressed as 
a percentage (%) of the distance traveled by the charcoal meal relative 
to the total length of the small intestine. The PI and percent inhibition 
relative to control were calculated according to Degu et al. [39] as follows:
PI=[LCM/LSI]×100%
Where: PI=Peristaltic Index
LCM=Length traveled by charcoal meal; LSI=Total length of small 
intestine
% Inhibition=[(A-T)/A]×100
Where A=Distance traveled by charcoal meal in control group and 
T=Distance traveled by charcoal meal in treated groups.
Effect of EEJ on castor oil-induced enteropooling
The rats were fasted for 24 h before the commencement of the 
experiment with free access to water. 42 rats were randomly allocated 
into 7 groups with 6 rats per group as follows:
Group I was administered with 2 ml/kg/bwt of normal saline and acted 
as a negative control. Groups II, III, and IV were administered 100, 200, 
and 400 mg/kg/bwt of EEJ, respectively. Group V was administered 
loperamide, a standard antidiarrheal drug at a dose of 5 mg/kg/bwt and 
acted as a positive control. In a separate experiment, rats in Groups VI 
and VII were pre-treated with yohimbine (1 mg/kg/bwt i.p) a selective 
α2 adrenergic receptor blocker and prazosin (1 mg/kg/bwt i.p), a 
selective α1 adrenergic receptor blocker, respectively, 30 min before 
the dose of 400 mg/kg of EEJ was administered. After 1 h rats in each 
group were orally administered 2 ml/kg/bwt of castor oil. 30 min later, 
each rat was sacrificed by cervical dislocation, and its abdomen was 
opened by midline incision, and small intestine was ligated at both the 
pyloric and the ileocaecal junctions before it was isolated and weighed. 
The intestinal contents were squeezed and emptied into the graduated 
measuring cylinder, and the volume of contents was recorded. The 
intestine was reweighed without the intestinal contents, and the 
difference between the full and empty intestines was calculated, and 
percent inhibition was determined.
Statistical analysis
GraphPad Prism software was used for all analysis. The data were 
presented as means plus or minus standard errors of the means (SEM). 
One-way analysis of variance (ANOVA) followed by Tukey multiple 
comparison tests was employed to compare the treatment means 
with control means. Student’s unpaired t-test was used to compare 




The median LC50 after the 24 h count using the probit statistical analysis 
method was found to be 1225 µg/ml and was considered non-toxic 
since it is >1000 µg/ml.
Effect of EEJ on castor-oil induced diarrhea
Oral administration of 2 ml of castor oil produced marked copious 
diarrhea in all rats in the vehicle-treated control group during the 4 h 
period of observation. Fig. 1a and b shows that oral administration of 
EEJ significantly (p<0.05) and dosedependently reduced the number 
of wet feces induced by castor oil, with groups of 100, 200, and 
400 mg/Kg/bwt producing 13, 5, and 0 number of wet feces, respectively, 
as compared with negative control group with 21 wet feces, after a 4 h 
period. A dose of 400 mg/Kg/bwt and loperamide (5 mg/Kg/bwt) 
Fig. 1: (a) The effect of oral administration of Eriobotrya japonica (EEJ) against castor oil-induced diarrhea. Values are presented as 
means±standard errors of the means (SEM) (n=6). *p<0.05; **p<0.01 significantly different compared with negative control group. (b) The 
percent protective effect of oral administration EEJ against castor oil-induced diarrhea. Values are presented as means±SEM (n=6). (c) The 
effect of oral administration of EEJ on the time of onset of castor oil-induced diarrhea. Values are presented as means±SEM (n=6). **p<0.01 
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caused complete inhibition of defecation, suggesting 100% protection, 
whereas EEJ at 100 mg/kg and 200 mg/kg offered 38.1% and 76.19% 
protection, respectively, against castor oil-induced diarrhea. Pre-
treatment with yohimbine significantly reversed the protective effect 
of EEJ (400 mg/kg) against castor oil-induced diarrhea (52.38% vs. 
100% when EEJ [400 mg/kg] was administered alone). Pre-treatment 
with prazosin did not significantly mitigate the protective effect of EEJ 
(400 mg/kg) against castor oil-induced diarrhea (97.62% vs. 100%) 
when EEJ (400 mg/kg) was administered alone. Fig. 1c, on the other 
hand, shows that EEJ at 100 mg/kg and 200 mg/kg significantly delayed 
the time of onset of wet feces (143±17 and 177±28 min. respectively. 
as compared with vehicle-treated control, 56±10 min). The presence 
of yohimbine caused the onset of wet feces in EEJ (400 mg/kg) treated 
group at the 146th min.
Effect of EEJ on castor oil-induced gastrointestinal enteropooling
Table 1 shows the effect of oral administration of EEJ on castor oil-induced 
intestinal fluid accumulation. Oral administration of EEJ significantly 
(p<0.05) and dosedependently (100, 200, and 400 mg/kg/bwt) reduced 
the volume of intestinal contents with percent inhibition of 24.37%, 
43.29%, and 79.83%, respectively, compared with the negative control 
group. The effect of EEJ (400 mg/kg) was comparable to loperamide 
(77.37%). The effect of EEJ at 400 mg/kg/bwt was significantly 
reversed in the presence of yohimbine (45.8% vs. 79.83% when EEJ 
[400 mg/kg]) was administered alone. Similarly, EEJ significantly and 
dosedependently (100, 200, and 400 mg/kg/bwt) reduced the weight 
of intestinal contents with percent inhibition of 26.82%, 45.8%, and 
78.41%, respectively, compared with the negative control group. The 
effect of EEJ (400 mg/kg) was comparable to loperamide (74.57%). 
The effect of EEJ at 400 mg/kg/bwt was significantly reversed in the 
presence of yohimbine (44.84% vs. 78.41% when EEJ [400 mg/kg]) 
was administered alone. The effect of EEJ at 400 mg/kg/bwt was not 
antagonized by prazosin.
Effect of EEJ on castor oil-induced gastrointestinal propulsion
Fig. 2a shows that oral administration of EEJ significantly (p<0.05) and 
dosedependently (100, 200, and 400 mg/kg/bwt) delayed the intestinal 
transit time of charcoal meal with PI of 61, 38.04, and 15.55, representing 
percent gastrointestinal motility reductions of 28%, 62%, and 83.92%, 
respectively (Fig. 2b), as compared with the negative control group 
with PI of 94.55. The effect of atropine at 0.3 mg/kg/bwt was more 
pronounced than that of EEJ at 400 mg/kg/bwt (95.92% vs. 83.92%), 
respectively. The propulsive inhibitory effect of EEJ at 400 mg/kg/bwt 
was significantly attenuated in the presence of yohimbine (64.7% vs. 
83.92% when EEJ [400 mg/kg]) was administered alone.
DISCUSSION
Diarrhea results from an imbalance between the gastrointestinal 
absorptive and secretory mechanisms leading to excessive fluid and 
electrolytes loss in the feces. It is evident enough that diarrhea occurs 
as a result of increased gastrointestinal motility and secretion as well 
as decreased intestinal fluid absorption. Therefore, antidiarrheal 
drugs work by inhibiting either gastrointestinal motility or secretion 
or both [40]. The present study has demonstrated the potential 
antidiarrheal properties of ethanolic leaf extract of EEJ in various 
models of experimental diarrhea, which may be attributable to its dual 
antisecretory and antimotility activities.
Na+/K+-ATPase is one of the intestinal key enzymes which plays an 
important role in the absorption of electrolytes and water in the 
intestine. Any disruption or inhibition of this enzyme may cause 
increased intestinal fluid secretion leading to diarrhea [41,42]. Castor 
oil-induced diarrhea is provoked by ricinoleic acid which, in part alters 
the intestinal mucosa permeability to electrolytes by interfering with 
the normal activity of Na+/K+-ATPase resulting in abnormal intestinal 
absorptive and secretory mechanisms [43,44]. In the present study, 
EEJ significantly inhibited castor oil-induced diarrhea probably by 
inhibiting intestinal lipase enzymatic activity on castor oil from 
liberating and releasing ricinoleic acid, an active metabolite of castor 
oil. Therefore, lack of availability of ricinoleic acid in the intestine 
indirectly ensured restoration of normal absorptive capacity of the 
Na+/K+-ATPase with the concomitant increased intestinal absorption of 
Na+ along with other electrolytes and water. Studies have demonstrated 
the potential of various herbal extracts to directly enhance the activities 
of Na+/K+-ATPase followed by apparent increased intestinal absorptive 
and decreased secretory capacity [45]. Similar argument may explain 
the possible direct stimulatory effect of EEJ on the activities of Na+/K+-
ATPase which might have led to the increased intestinal absorptive 
and decreased secretory capacity resulting in protection against castor 
oil-induced diarrhea. Thus, EEJ may contain phytochemicals with 
both direct and indirect stimulatory activity on the Na+/K+-ATPase 
Table 1: The effect of EEJ on castor oil-induced intestinal fluid accumulation
Treatment VIC (ml) % inhibition WIC (g) % inhibition
Vehicle-treated control 5.572±0.301++ 5.631±0.26++
EEJ (100 mg/kg/bwt) 4.214±0.231*++ 24.37 4.121±0.287*+ 26.82
EEJ (200 mg/kg/bwt) 3.16±0.147*+ 43.29 3.052±0.170*+ 45.8
EEJ (400 mg/kg/bwt) 1.124±0.221** 79.83 1.216±0.162** 78.41
EEJ (400+yohimbine) 3.02±0.331*+ 45.8 3.106±0.314*+ 44.84
EEJ (400+prazosin) 1.218±0.18** 78.14 1.303±0.231** 76.86
Loperamide 1.261±0.32** 77.37 1.432±0.115** 74.57
Values are presented as means±SEM (n=6). *p<0.05; **p<0.01 significantly different compared with negative control group and+p < 0.05; ++p<0.01 significantly different 
compared with EEJ (400 mg/kg/bwt). EEJ: Eriobotrya japonica, VIC: Volume of intestinal content in ml, WIC: Weight of intestinal content in g
Fig. 2: (a) The effect of Eriobotrya japonica (EEJ) on gastrointestinal motility. Values are presented as means±standard errors of the means 
(SEM) (n=6). *p<0.05; **p<0.01 significantly different compared with negative control group and+p<0.05 significantly different compared 
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on the intestinal mucosa. Therefore, the resultant effect of EEJ due to 
its indirect and direct activation of Na+/K+-ATPase on the intestinal 
mucosa is decreased and increased gastrointestinal secretion and 
absorption, respectively, leading to marked reduction in fecal output 
and hence diarrhea.
The other possible mechanistic pathway through which ricinoleic acid 
triggers diarrhea is by activation of nitric oxide (NO) pathway. Ricinoleic 
acid is potentially cytotoxic to intestinal epithelial cells and causes increased 
mucosal permeability which is associated with increased intraluminal 
fluid accumulation [39]. NO is produced in response to cytotoxins such 
as ricinoleic acid to intestinal epithelial cells, thereby playing a protective 
role against cytotoxic-induced intestinal damage. Moreover, studies 
have demonstrated that pre-treatment of animals with L-NAME, a NO 
synthase inhibitor attenuates or prevents castor oil-induced diarrhea [46]. 
Therefore, it would be scientifically reasonable to suggest that certain 
phytochemicals contained in EEJ might have interfered with the NO 
pathway resulting in decreased NO synthesis and subsequently, decreased 
intestinal fluid secretion. On the other hand, considering that EEJ is crude 
extract, it is obvious that it contains large amount of fiber including protein 
tannates which make the intestinal mucosa more resistant and decrease 
secretion with a concomitant enhancement of intestinal absorption.
The enteric nervous system consisting of the myenteric and the 
submucosal, regulate the activities of the gastrointestinal tract through 
the secretomotor nerves that release agonists with either direct or 
indirect effects on epithelial ion transport. Vasoactive intestinal peptide 
and acetylcholine are the predominant transmitters with direct epithelial 
secretory effects released by secretomotor nerves [47]. Norepinephrine 
is the predominant sympathetic neurotransmitter and an agonist in 
the intestines. Activation of the sympathetic pathway through α2-
adrenoceptors on enterocytes in the intestines causes inhibition of 
motor function of the intestines leading to inhibition of intestinal 
motility and secretion [48]. The present study has demonstrated the 
significant protective effect of EEJ against castor oil-induced diarrhea and 
enteropooling, with the highest dose of 400 mg/kg/bwt offering 100% 
protection against castor oil-induced diarrhea and 88% against castor oil 
induced enteropooling, the effects of which were favorably comparable 
to that of loperamide, a standard antisecretory drug. The study further 
showed that the antisecretory activity of EEJ is in part mediated through 
activation of α2-adrenoceptors and not α1-adrenoceptors. This view was 
substantiated by comparing the protective effect of EEJ at 400 mg/kg/
bwt in the absence and presence of yohimbine and prazosin against 
castor oil-induced diarrhea and enteropooling. EEJ at 400 mg/kg/bwt 
significantly reversed the gastrointestinal secretory effect of castor oil in 
the absence of yohimbine. However, this remarkable antisecretory effect 
of EEJ at 400 mg/kg/bwt was successfully antagonised by yohimbine, a 
selective α2-adrenoceptor blocker. Considering the significant protective 
effect of this highest dose of EEJ against castor oil-induced diarrhea and 
enteropooling, and its failure to demonstrate likewise in the presence 
of yohimbine, it would seem to suggest that the antisecretory activity of 
EEJ is mediated in part, through activation of α2-adrenoceptors, which 
resulted in marked inhibition of secretion-inducing neurotransmitters 
on the secretomotor nerves, thereby enhancing absorption. On the other 
hand, the protective effects of EEJ at 400 mg/kg/bwt against castor 
oil-induced diarrhea and enteropooling were significantly resistant to 
antagonism by the α1-adrenoceptors antagonist, prazosin. Therefore, 
failure of prazosin to significantly reverse the protective effect of highest 
dose of EEJ against castor oil-induced diarrhea and enteropooling, 
precludes the involvement of α1-adrenoceptors in the antisecretory 
activity of EEJ.
The presently described study has further demonstrated the significant 
inhibitory activity of EEJ against castor oil induced gastrointestinal 
propulsion. EEJ significantly reduced the PI in a dose-dependent 
fashion as demonstrated by its ability to reduce the distance traveled 
by a charcoal meal in the small intestine. The antimotility activity of 
EEJ would reduce the number and frequency of defecations, thereby 
preventing diarrhea. On the other hand, the decrease in gastrointestinal 
propulsion would allow intestinal contents more time of contact with 
the intestinal mucosa for the absorption which ultimately would reduce 
fecal output.
It is well established that activation of the sympathetic nervous 
system enhances fluid and electrolyte absorption through inhibition 
of gastrointestinal motility. Moreover, strong evidence suggests that 
activation of α2-adrenoceptors by various agonists mediate inhibition 
of smooth muscle contraction and hence peristalsis in small intestine 
probably through inhibition of acetylcholine release from enteric 
cholinergic nerves [49,50]. Thus, in addition, the present study has 
showed that the antimotility activity of EEJ was in part, mediated 
through activation of α2-adrenoceptors, since the antimotility activity 
of EEJ at 400 mg/kg/bwt against castor oil-induced gastrointestinal 
propulsion was significantly attenuated in the presence of yohimbine, 
a selective α2-adrenoceptor antagonist, probably through inhibition of 
acetylcholine release from enteric cholinergic nerves.
The present findings on the effect of EEJ on gastrointestinal motility are 
partly in agreement with Matimba et al. [51], who reported the anti-
spasmolytic activity of ethanolic leaf extract of EEJ on isolated rabbit 
ileum in vitro and this relaxant effect was suggested to be mediated 
through blockade of histamine and muscarinic receptors.
Use of medicinal plants as therapies for various diseases has over 
years gained popularity partly due to the common belief that they are 
safe and have fewer side effects. However, many plant-based products 
may be toxic and have significant adverse effects on human beings. It 
is, therefore, imperative that potential toxicity of medicinal plants be 
determined before consumption of the plant materials. The present 
study carried out the toxicity study of EEJ using a simple and rapid brine 
shrimp lethality assay. This assay is widely employed in toxicological 
tests involving screening of large numbers of medicinal plant extracts 
for drug discovery [52,53] and as a matter of fact, some studies have 
reported significant correlation between the LC50 value obtained with 
brine shrimp lethality assay and the LD50 value obtained from the 
acute oral toxicity assay done in mice [54]. Therefore, this assay could 
conveniently and potentially replace other biological models such 
as in vivo assays involving the use of live laboratory animals which 
are constantly facing ethical issues. The study has demonstrated that 
EEJ is not toxic as determined by its higher LD50 value of 1225 µg/ml, 
probably suggesting safety of EEJ for human consumption. However, 
the fact that EEJ at 400 mg/kg/bwt completely abolished defecation 
during the entire experimental duration just as loperamide did, it may 
seem to appear that, higher doses of EEJ may induce constipation, 
which is yet another gastrointestinal problem affecting many people 
worldwide [55]. Thus, it may be advisable that consumption of 
the materials derived from this plant be done with some degree of 
cautiousness especially at higher doses.
CONCLUSION
The present study has demonstrated the potential antidiarrheal 
properties of ethanolic leaf extract of EEJ using various models of 
experimental diarrhea. The extract seems to mediate its antidiarrheal 
activity in part, through activation of α2-adrenoceptors. The extract 
may also, on the other hand, mediate its effect through modulation of 
the Na+/K+-ATPase and NO pathways. Therefore, extracts from EEJ, if 
properly and adequately standardized, may serve as a safe and cost-
effective, potential therapeutic agent, with antidiarrheal properties. 
The study has shed more light on the scientific basis for the use of 
EEJ in the treatment of diarrhea and other associated gastrointestinal 
disorders by some communities of the Eastern Cape Province of the 
Republic of South Africa.
Limitations and recommendations
The present study has established only one mechanistic pathway 
through which EEJ mediates its antidiarrheal effect, yet the other 
mentioned mechanisms are mainly based on speculations. Therefore, 
further investigations are warranted to establish other mechanistic 
pathways, through which, EEJ exerts its antidiarrheal actions. 
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Furthermore, the study did not carry out a phytochemical analysis of 
the extract as such it is imperative that future studies should focus on 
identification, isolation, and screening of the active compounds for 
their antidiarrheal properties.
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